Aspire Biopharma dismisses auditor Turner Stone, taps CBIZ as replacement
The company said Turner Stone’s audit report for 2025 included a going-concern paragraph. It said CBIZ CPAs will serve as auditor for fiscal 2026, effective immediately.
The company said Turner Stone’s audit report for 2025 included a going-concern paragraph. It said CBIZ CPAs will serve as auditor for fiscal 2026, effective immediately.